This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07867/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/drug/DB07867/identifier/pubchem-substance/
n5http://linked.opendata.cz/resource/drugbank/drug/DB07867/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07867/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07867/identifier/pdb/

Statements

Subject Item
n2:DB07867
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n10:DB07867 n13:DB07867
dcterms:title
6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE
adms:identifier
n4:99444338 n5:DB07867 n8:H12 n11:395439 n14:448724
n6:IUPAC-Name
n7:271B4708-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B470E-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B470D-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B470A-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B470B-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B470C-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B4706-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B4707-363D-11E5-9242-09173F13E4C5 n7:271B4704-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B4705-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B4714-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B4715-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B470F-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4710-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4712-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4711-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4713-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B471A-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B471C-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B471D-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B4719-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B4718-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B471B-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B4709-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B4716-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B4717-363D-11E5-9242-09173F13E4C5